Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticles Hitchhike on Monocytes for Glioblastoma Treatment after Low-Dose Radiotherapy
Jing Kuang, Zhi‐Yong Rao, Di‐Wei Zheng, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13333-13347
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Biomarker-driven molecular imaging probes in radiotherapy
Haonan Li, Qiyong Gong, Kui Luo
Theranostics (2024) Vol. 14, Iss. 10, pp. 4127-4146
Open Access | Times Cited: 75
In situ cellular hitchhiking of nanoparticles for drug delivery
Edidiong Udofa, Zongmin Zhao
Advanced Drug Delivery Reviews (2023) Vol. 204, pp. 115143-115143
Open Access | Times Cited: 27
Immune-enhanced and tumor-targeted PDT cascade therapy for oral squamous cell carcinoma utilizing a carrier-free BRD4 inhibitor/PDT agent nanocomplex
Jiechen Liu, Guangrui Liu, Chunlei Dai, et al.
Chemical Engineering Journal (2024) Vol. 485, pp. 149446-149446
Closed Access | Times Cited: 13
Cathepsin B-Responsive Programmed Brain Targeted Delivery System for Chemo-Immunotherapy Combination Therapy of Glioblastoma
Shaoping Jiang, Wenpei Li, Jun Yang, et al.
ACS Nano (2024) Vol. 18, Iss. 8, pp. 6445-6462
Closed Access | Times Cited: 13
Enzyme-responsive liposomes for controlled drug release
Yan Wei, Jiajing Lv, Shiyu Zhu, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104014-104014
Closed Access | Times Cited: 13
Cell-mediated nanoparticle delivery systems: towards precision nanomedicine
Ruoyu Cheng, Shiqi Wang
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 11, pp. 3032-3054
Open Access | Times Cited: 12
Recent Advances in Biomimetic Strategies for the Immunotherapy of Glioblastoma
Haoyu You, Shuo Geng, Shangkuo Li, et al.
Biomaterials (2024) Vol. 311, pp. 122694-122694
Closed Access | Times Cited: 8
Navigating the Brain: Harnessing Endogenous Cellular Hitchhiking for Targeting Neoplastic and Neuroinflammatory Diseases
Suraj Wagh, Paras Famta, Saurabh Shah, et al.
Asian Journal of Pharmaceutical Sciences (2025), pp. 101040-101040
Open Access | Times Cited: 1
MRI Detection of Lymph Node Metastasis through Molecular Targeting of C–C Chemokine Receptor Type 2 and Monocyte Hitchhiking
Noah Trac, Zixi Chen, Hyun-seok Oh, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 2091-2104
Closed Access | Times Cited: 6
Inflammation-Driven Nanohitchhiker Enhances Postoperative Immunotherapy by Alleviating Prostaglandin E2-Mediated Immunosuppression
Yingke Liu, Jiao He, Man Li, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 6, pp. 6879-6893
Closed Access | Times Cited: 6
Renal Clearable Nanodots‐Engineered Erythrocytes with Enhanced Circulation and Tumor Accumulation for Photothermal Therapy of Hepatocellular Carcinoma
Quanxiao Li, Meng Jin, Zhen Ding, et al.
Small (2024) Vol. 20, Iss. 25
Closed Access | Times Cited: 5
Blood-brain barrier penetrating nanosystems enable synergistic therapy of glioblastoma
Yajing Sun, Ming Li, Meng Zheng, et al.
Nano Today (2024) Vol. 56, pp. 102310-102310
Open Access | Times Cited: 5
Applications of nanotechnology in remodeling the tumour microenvironment for glioblastoma treatment
Yulei Mu, Zhen Zhang, Huiqun Zhou, et al.
Biomaterials Science (2024) Vol. 12, Iss. 16, pp. 4045-4064
Closed Access | Times Cited: 5
Synthetic Biology‐Based Engineering Cells for Drug Delivery
Wenzhe Yi, Songnian Hu, Xindi Qian, et al.
Exploration (2025)
Open Access
Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors
Iaroslav B. Belyaev, Olga Yu. Griaznova, Alexey V. Yaremenko, et al.
Advanced Drug Delivery Reviews (2025), pp. 115550-115550
Open Access
The application strategy of liposomes in organ targeting therapy
Zengyu Xun, Tianqi Li, Xue Xue
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 2
Closed Access | Times Cited: 4
Nomadic Nanomedicines: Medicines Enabled by the Paracrine Transfer Effect
Krishna Paranandi, Eliz Amar‐Lewis, Chad A. Mirkin, et al.
ACS Nano (2025)
Closed Access
Modern insights of nanotheranostics in the glioblastoma: An updated review
Roopkumar Sangubotla, Kumar Shiva Gubbiyappa, Rajakumari Devarapogu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167653-167653
Closed Access
Nanoparticle-based Drug Delivery Systems to Modulate Tumor Immune Response for Glioblastoma Treatment
Yan-Juan Xiong, Maoyuan Sun, Qingzhu Yang, et al.
Acta Biomaterialia (2025)
Closed Access
Cascade-Type Microglial Pyroptosis Inhibitors for Enhanced Treatment of Cerebral Ischemia-Reperfusion Injury
Zhi-Fei Cheng, Wei Shao, Chaoqi Wei, et al.
ACS Nano (2025)
Closed Access
Bioinspired Lipoproteins of Furoxans–Gemcitabine Preferentially Targets Glioblastoma and Overcomes Radiotherapy Resistance
Maoyuan Sun, Honglei Xie, Wenli Zhang, et al.
Advanced Science (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 10
Active-Targeting Biomimetic Polymer Nanoparticles for NIR Fluorescence Imaging and Enhanced Chemo-Sonodynamic Therapy of Cancer
Rui‐Mei Jin, Guangchuan Zhang, Lulu Tang, et al.
ACS Applied Nano Materials (2024) Vol. 7, Iss. 4, pp. 3968-3976
Closed Access | Times Cited: 3
Interfering tumor metabolism by bimetallic nanoagent for amplifying nanocatalytic-mediated glioblastoma immunotherapy
Qian‐Xiao Huang, Jun‐Long Liang, Mei‐Ting Niu, et al.
Nano Today (2024) Vol. 56, pp. 102253-102253
Closed Access | Times Cited: 3
X-ray-activatable hitchhiking polymer nanodrugs enable controllable ferroptosis and immunization for orthotopic glioma rejection
Anni Zhu, Wenzhi Tu, Mengbin Ding, et al.
Chemical Engineering Journal (2024) Vol. 497, pp. 154652-154652
Closed Access | Times Cited: 3
Glioma nanomedicine: Design, fabrication and theranostic application
Dejun Wu, Jiajia Zhao, Tao Xu, et al.
Coordination Chemistry Reviews (2024) Vol. 505, pp. 215696-215696
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top